Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

AI-Based Video Analysis for Motor Development Assessment in Children (AMD-AI)

15 maggio 2026 aggiornato da: Abdullah Furkan Cangi, Medipol University

Development and Validation of an Artificial Intelligence-Based System for Assessing Motor Development in Children Using Video Analysis

This is a non-interventional, prospective observational study aimed at developing and validating an artificial intelligence-based system for assessing motor development in children using video analysis. Children aged 5 to 10 years will perform standardized motor tasks, which will be recorded under controlled conditions. The recorded videos will be analyzed using computer vision and deep learning techniques to extract movement patterns.

The results of the AI-based analysis will be compared with standardized motor assessment scores obtained from the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition - Short Form (BOT-2 SF). Participants will be classified into typical and atypical motor development groups based on BOT-2 scores. The primary objective is to evaluate the classification performance of the AI model. Secondary analyses will examine the relationship between AI predictions and continuous motor performance scores.

The study is designed to explore whether motor development can be assessed objectively without direct clinical testing, using only short video recordings. The findings may contribute to the development of scalable and accessible digital screening tools for early identification of motor development differences in children.

Panoramica dello studio

Descrizione dettagliata

This study is a prospective, non-interventional observational study conducted to develop and validate an artificial intelligence-based system for the assessment of motor development in children. The study includes children aged between 5 and 10 years who have no previously diagnosed neurological, developmental, or orthopedic disorders.

All participants will complete the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition - Short Form (BOT-2 SF), which will serve as the reference standard for motor performance. Based on BOT-2 scores, participants will be categorized into typical and atypical motor development groups using predefined thresholds derived from normative data and statistical distribution methods.

In addition to standardized testing, participants will perform a series of structured motor tasks, including jumping jacks, tandem walking, skipping, single-leg balance, finger-to-nose coordination, and protective extension responses. These tasks will be recorded using high-resolution video under controlled environmental conditions.

Video data will be processed using computer vision pipelines. Skeletal keypoints will be extracted using pose estimation models, and silhouette segmentation will be obtained using deep learning-based segmentation models. Extracted features will be normalized and used as input for machine learning and deep learning architectures, including transformer-based models and graph-based networks.

The primary outcome is the classification performance of the AI model in distinguishing typical versus atypical motor development profiles, evaluated using metrics such as ROC-AUC, accuracy, sensitivity, specificity, F1-score, and balanced accuracy. Secondary outcomes include regression performance for predicting continuous motor scores, evaluated using MAE, RMSE, and R-squared values.

Inter-rater reliability of expert evaluations will be assessed using intraclass correlation coefficients (ICC). Additional analyses will include error distribution examination and Bland-Altman analysis to assess agreement between AI predictions and standardized test scores.

This study does not involve any intervention, treatment, or risk beyond standard observational procedures. All participants are healthy volunteers, and informed consent will be obtained from parents or legal guardians. The study has been approved by the Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee.

Tipo di studio

Osservativo

Iscrizione (Stimato)

60

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino

Accetta volontari sani

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population consists of children aged 5 to 10 years recruited from schools and clinical settings. All participants are typically developing individuals without prior diagnoses, and they are evaluated to identify variations in motor development patterns using standardized testing and video-based analysis.

Descrizione

Inclusion Criteria:

  • Children aged between 5 and 10 years
  • No diagnosed neurological, developmental, or orthopedic disorders
  • Ability to follow verbal instructions
  • Informed consent obtained from parents or legal guardians
  • No prior participation in sensory integration therapy or special education programs

Exclusion Criteria:

  • Diagnosed neurological, developmental, or orthopedic conditions (e.g., autism spectrum disorder, cerebral palsy, epilepsy)
  • Visual or hearing impairments affecting task performance
  • Severe attention or behavioral problems preventing test completion
  • Physical limitations preventing participation in motor tasks

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Typical Motor Development
Children classified as having typical motor development based on BOT-2 scores. This group represents the control group for comparison with atypical motor development profiles.
This study does not include any therapeutic or experimental intervention. The procedures are limited to observational assessment and data collection. Participants perform standardized motor tasks and are video recorded under controlled conditions. No treatment, training, or behavioral modification is applied. The collected data are analyzed using artificial intelligence-based methods to evaluate motor development patterns.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
AI-Based Classification Accuracy of Motor Development
Lasso di tempo: Baseline assessment (Day 1)
Classification accuracy of the artificial intelligence model in distinguishing typical versus atypical motor development based on video analysis, using the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total score as the reference standard. BOT-2 SF scores range from 0 to 88, with higher scores indicating better motor proficiency.
Baseline assessment (Day 1)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Correlation Between AI Predictions and BOT-2 Scores
Lasso di tempo: Baseline assessment (Day 1)
Statistical relationship between artificial intelligence-generated motor development predictions and Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores. BOT-2 SF scores range from 0 to 88, with higher scores indicating better motor proficiency.
Baseline assessment (Day 1)
Mean Absolute Error of AI-Based Motor Score Prediction
Lasso di tempo: Baseline assessment (Day 1)
Mean absolute error (MAE) of the artificial intelligence model in predicting continuous motor development scores based on video analysis, compared with Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores.
Baseline assessment (Day 1)
Root Mean Square Error of AI-Based Motor Score Prediction
Lasso di tempo: Baseline assessment (Day 1)
Root mean square error (RMSE) of the artificial intelligence model in predicting continuous motor development scores based on video analysis, compared with Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores.
Baseline assessment (Day 1)
R-Squared Performance of AI-Based Motor Score Prediction
Lasso di tempo: Baseline assessment (Day 1)
Coefficient of determination (R-squared) for the artificial intelligence model in predicting continuous motor development scores based on video analysis, compared with Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores.
Baseline assessment (Day 1)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Collegamenti utili

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 gennaio 2026

Completamento primario (Stimato)

1 agosto 2026

Completamento dello studio (Stimato)

1 settembre 2026

Date di iscrizione allo studio

Primo inviato

29 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 maggio 2026

Primo Inserito (Effettivo)

19 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

19 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • AMD-2026-01

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Motor Development Assessment

Prove cliniche su Observational Assessment Only

Sottoscrivi